Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report

被引：1
|
作者：
Wang Xiao-Pei
Hu Zhang-Xue
Guo Dong-Yang
Tao Ye
机构：
[1] Chengdu
[2] Chengdu Military General Hospital
[3] Department of Nephrology
[4] Sichuan 610041
[5] Sichuan 610083
[6] Sichuan University
[7] West China Hospital
来源：
中华医学杂志英文版 | 2016年 / 129卷 / 07期
关键词：
Low-dose; Primary Membranous Nephropathy; Remission; Rituximab;
D O I：
暂无
中图分类号：
R692 [肾疾病];
学科分类号：
摘要：
Primary membranous nephropathy (PMN) is an antibody-mediated autoimmune glomerular disease. The incidence of PMN is 10/million populations/year and mostly adult patients present with nephrotic syndrom
引用
收藏
页码：871 / 873
页数：3
相关论文
共 50 条
  • [1] Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
    Wang, Xiao-Pei
    Hu, Zhang-Xue
    Guo, Dong-Yang
    Tao, Ye
    CHINESE MEDICAL JOURNAL, 2016, 129 (07) : 871 - 873
  • [2] Low-Dose Rituximab for Posttransplant Recurrent Membranous Nephropathy
    Cravedi, P.
    Ruggenenti, P.
    Remuzzi, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1336 - 1336
  • [3] Combination of Rituximab and Low-dose Tacrolimus in the Treatment of Refractory Membranous Nephropathy: A Retrospective Cohort Study
    Chen, Xian
    Jiao, Sumin
    Li, Shaomei
    Li, Juan
    Li, Pei
    Song, Fang
    Yan, Zhe
    BALKAN MEDICAL JOURNAL, 2023, 40 (04) : 287 - 293
  • [4] A case report of remission of refractory membranous nephropathy progressing to stage 4 chronic kidney disease using low-dose rituximab A long-term follow-up
    Zhou, Xu-Jie
    Zhou, Fu-De
    Wang, Su-Xia
    Zhao, Ming-Hui
    MEDICINE, 2018, 97 (25)
  • [5] Low-dose rituximab is poorly effective in patients with primary membranous nephropathy
    Moroni, Gabriella
    Depetri, Federica
    Del Vecchio, Lucia
    Gallelli, Beniamina
    Raffiotta, Francesca
    Giglio, Elisa
    Brunini, Francesca
    D'Amico, Marco
    Longhi, Selena
    Radice, Antonella
    Messa, Piergiorgio
    Sinico, Renato Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (10) : 1691 - 1696
  • [6] Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
    Vink, Coralien H.
    Wetzels, Jack F. M.
    van de Logt, Anne-Els
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (12): : 3439 - 3445
  • [7] Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
    Cortazar, Frank B.
    Leaf, David E.
    Owens, Charles T.
    Laliberte, Karen
    Pendergraft, William F., III
    Niles, John L.
    BMC NEPHROLOGY, 2017, 18 : 1 - 10
  • [8] Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
    Frank B. Cortazar
    David E. Leaf
    Charles T. Owens
    Karen Laliberte
    William F. Pendergraft
    John L. Niles
    BMC Nephrology, 18
  • [9] Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
    Yao-Wei Wang
    Xin-Hui Wang
    Hong-Xia Wang
    Ren-Huan Yu
    World Journal of Clinical Cases, 2023, (03) : 566 - 575
  • [10] Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
    Wang, Yao-Wei
    Wang, Xin-Hui
    Wang, Hong-Xia
    Yu, Ren-Huan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (03) : 566 - 575
12345